In Focus this month:
- PEPFAR 3.0: Delivering on the Promise of an AIDS-free Generation (OGAC)
This report on phase three of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR 3.0, 2014–2018) describes PEPFAR's strategy to lay the foundation for an AIDS-free generation through five action agendas focusing on: (1) impact, (2) efficiency, (3) sustainability, (4) partnership, and (5) human rights.
- Unsupervised Self-Testing for HIV Testing is Feasible in Rural Africa (AIDS and Behavior)
This trial in three rural fishing communities in Western Uganda investigated whether unsupervised HIV self-testing (HST) was equivalent to provider-supervised HST in terms of clinical accuracy. The trial results showed a 90 percent sensitivity of unsupervised oral HST, suggesting that unsupervised HST is feasible in rural African settings.
- Increase Access to HIV Treatment to Maximize Option B Benefits (Journal of Acquired Immune Deficiency Syndromes)
This study in Botswana found that pregnant women who received Option B or B+ during antenatal care (ANC) were less likely to receive antenatal antiretroviral treatment (ART) than women receiving Option A, which increased the likelihood of mother-to-child transmission under Option B. The authors recommended providing ART within ANC settings (rather than referring clients) to enhance the benefits of the national rollout of Option B.